GSK3B and Alzheimer disease: Conversely, inhibition of GSK3β leads to reduction of β-amyloid production (Rockenstein et al., 2007) and its toxicity (Koh et al., 2008), reduction of phosphorylated tau in cultured neurons (Zhang et al., 2011) and improves learning and memory in AD mouse models (Farr et al., 2016).